Merck Hits Barr With Suit Over Generic Fosamax
Continuing its campaign to protect blockbuster osteoporosis drug Fosamax, Merck & Co.'s has filed another suit against a generic maker seeking to market its own version of the drug....To view the full article, register now.
Already a subscriber? Click here to view full article